NMTC

NASDAQStock

NeuroOne Medical Technologies Corporation

$0.77-0.02 (-2.95%)

52-Week Range

$0.43

$1.08

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

0.69

Volume

61.5K

Avg Volume

230.2K

Performance

+4.56%

+19.29%

-10.40%

YTD

-7.49%

-26.99%

-53.89%

-89.11%

Price Chart

ETF Exposure

NMTC is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VXF	Vanguard Extended Market ETF	0.00%	542,756	$480K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	42	$50	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,501	$2K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	7	$8	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	854,573	$756K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	4,494	$5K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	387	$464	$1.29B	0.17%

About NMTC ETF Exposure

NeuroOne Medical Technologies Corporation (NMTC) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $0.77. Investors can gain exposure to NMTC through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NMTC, sorted by portfolio weight.